chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 50.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Blood pressure measurement, Dizziness, Nausea
Clinical narrative: Extreme dizziness; Nausea; This is a spontaneous report from a contactable consumer, the patient. A 50-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8733), via an unspecified route of administration in the left arm on 29Mar2021(at the age of 50-years-old), as a single dose for COVID-19 immunisation. Medical history included high blood pressure. The patient did not have any allergies to medications, food, or other products. The patient received medications for blood pressure within 2 weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6206), via an unspecified route of administration in the left arm on 07Mar2021 at 17:30 (at the age of 50-years-old), as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the vaccination. On 30Mar2021 at 01:00, the patient experienced dizziness and nausea. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of the reported events. The clinical outcome of the events dizziness and nausea were not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 60.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chills, Headache, Nausea, Pain in extremity, Tremor
Clinical narrative: Slight sore arm; Severe headache; chills; nausea; vomiting; This is a spontaneous report from a contactable healthcare professional, the patient. A 60-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EW0150), via an unspecified route of administration in the left arm on 01Apr2021 at 10:45 (at the age of 60-years-old) as a single dose for COVID-19 immunisation. Medical history included osteoporosis, alopecia areata (not chronic but recent) and penicillin allergy. Concomitant medications included loratadine (CLARITIN), ascorbic acid; calcium; minerals nos, retinol; tocopheryl acetate; vitamin b nos; vitamins nos; zinc (CENTRUM SILVER) and others (unspecified).  Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 02Apr2021 at 08:00, the patient experienced slight sore arm, severe headache, chills, nausea and vomiting. The headache started within 24 hours of the vaccine.  It became worst and most severe approximately around 32 hours after the vaccination.  The severe headache and chills lasted for approximately 26 hours after they started. The adverse events did not result in a visit to the doctors or other healthcare professional office/clinic visit and emergency room/department or urgent care. The patient did not receive any treatment for the events slight sore arm, severe headache, chills, nausea and vomiting. The clinical outcome of the events slight sore arm, nausea and vomiting was resolved on an unspecified date in Apr2021. The clinical outcome of the events severe headache and chills was resolved on 03Apr2021 at 10:00.   No follow-up attempts are needed. No further information is expected.
Age: 60.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Vomiting
Clinical narrative: Slight sore arm; Severe headache; chills; nausea; vomiting; This is a spontaneous report from a contactable healthcare professional, the patient. A 60-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EW0150), via an unspecified route of administration in the left arm on 01Apr2021 at 10:45 (at the age of 60-years-old) as a single dose for COVID-19 immunisation. Medical history included osteoporosis, alopecia areata (not chronic but recent) and penicillin allergy. Concomitant medications included loratadine (CLARITIN), ascorbic acid; calcium; minerals nos, retinol; tocopheryl acetate; vitamin b nos; vitamins nos; zinc (CENTRUM SILVER) and others (unspecified).  Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 02Apr2021 at 08:00, the patient experienced slight sore arm, severe headache, chills, nausea and vomiting. The headache started within 24 hours of the vaccine.  It became worst and most severe approximately around 32 hours after the vaccination.  The severe headache and chills lasted for approximately 26 hours after they started. The adverse events did not result in a visit to the doctors or other healthcare professional office/clinic visit and emergency room/department or urgent care. The patient did not receive any treatment for the events slight sore arm, severe headache, chills, nausea and vomiting. The clinical outcome of the events slight sore arm, nausea and vomiting was resolved on an unspecified date in Apr2021. The clinical outcome of the events severe headache and chills was resolved on 03Apr2021 at 10:00.   No follow-up attempts are needed. No further information is expected.
Age: 60.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chills, Headache, Nausea, Pain in extremity, Vomiting
Clinical narrative: Slight sore arm; Severe headache; chills; nausea; vomiting; This is a spontaneous report from a contactable healthcare professional, the patient. A 60-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EW0150), via an unspecified route of administration in the left arm on 01Apr2021 at 10:45 (at the age of 60-years-old) as a single dose for COVID-19 immunisation. Medical history included osteoporosis, alopecia areata (not chronic but recent) and penicillin allergy. Concomitant medications included loratadine (CLARITIN), ascorbic acid; calcium; minerals nos, retinol; tocopheryl acetate; vitamin b nos; vitamins nos; zinc (CENTRUM SILVER) and others (unspecified).  Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 02Apr2021 at 08:00, the patient experienced slight sore arm, severe headache, chills, nausea and vomiting. The headache started within 24 hours of the vaccine.  It became worst and most severe approximately around 32 hours after the vaccination.  The severe headache and chills lasted for approximately 26 hours after they started. The adverse events did not result in a visit to the doctors or other healthcare professional office/clinic visit and emergency room/department or urgent care. The patient did not receive any treatment for the events slight sore arm, severe headache, chills, nausea and vomiting. The clinical outcome of the events slight sore arm, nausea and vomiting was resolved on an unspecified date in Apr2021. The clinical outcome of the events severe headache and chills was resolved on 03Apr2021 at 10:00.   No follow-up attempts are needed. No further information is expected.
Age: 45.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Lymph node pain, Lymphadenopathy
Clinical narrative: Painful swelling of lymph nodes near right collarbone.; This is a spontaneous report from a contactable consumer, the patient. A 45-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6206), via an unspecified route of administration in the arm right on 26Mar2021, at 12:00(at the age of 45-year-old), as a single dose for COVID-19 immunisation. Medical history included anxiety and depression. Concomitant medications included lithium (MANUFACTURER UNKNOWN) from an unknown date for an unknown indication, melatonin (MANUFACTURER UNKNOWN) from from an unknown date for unknown indication, escitalopram oxalate (LEXAPRO) from an unknown date for unknown indication, lamotrigine (MANUFACTURER UNKNOWN) from an unknown date for unknown indication and clonazepam (KLONOPIN) from from an unknown date for unknown indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 1Apr2021 at 20:00, the patient experienced painful swelling of lymph nodes near right collarbone. The patient did not receive any treatment for the event. The adverse event resulted in doctor or other healthcare professional office/clinic visit. The clinical outcome of the event painful swelling of lymph nodes near right collarbone was recovering.   No follow-up attempts are needed. No further information is expected.
Age: 45.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Lymphadenopathy
Clinical narrative: Painful swelling of lymph nodes near right collarbone.; This is a spontaneous report from a contactable consumer, the patient. A 45-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6206), via an unspecified route of administration in the arm right on 26Mar2021, at 12:00(at the age of 45-year-old), as a single dose for COVID-19 immunisation. Medical history included anxiety and depression. Concomitant medications included lithium (MANUFACTURER UNKNOWN) from an unknown date for an unknown indication, melatonin (MANUFACTURER UNKNOWN) from from an unknown date for unknown indication, escitalopram oxalate (LEXAPRO) from an unknown date for unknown indication, lamotrigine (MANUFACTURER UNKNOWN) from an unknown date for unknown indication and clonazepam (KLONOPIN) from from an unknown date for unknown indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 1Apr2021 at 20:00, the patient experienced painful swelling of lymph nodes near right collarbone. The patient did not receive any treatment for the event. The adverse event resulted in doctor or other healthcare professional office/clinic visit. The clinical outcome of the event painful swelling of lymph nodes near right collarbone was recovering.   No follow-up attempts are needed. No further information is expected.
Age: 40.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Nausea
Clinical narrative: Very strong nausea; This is a spontaneous report from a contactable consumer, the patient. A 40-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER8732), via an unspecified route of administration in the arm left on 26Mar2021 at 16:00 (at the age of 40-years-old), as a single dose for COVID-19 immunisation. Medical history included occasional premature ventricular contractions (PVC) of the heart. Concomitant medications included iron (MANUFACTURER UNKNOWN), vitamin d nos (MANUFACTURER UNKNOWN) and Cyanocobalamin (VITAMIN B12 SUPPLEMENTS); all taken for unknown indication and for unknown dates. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 27Mar2021 at 02:30, the patient was sleeping awakened by very strong nausea. The patient, felt like wave after wave of nausea in rapid succession. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the nausea. The duration of the event nausea was 1.5 hours. The clinical outcome of the event very strong nausea was resolved at 27Mar2021 at 04:00.  No follow-up attempts are needed. No further information is expected.
Age: 56.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Fatigue, Malaise, Nausea, Pain in extremity, Vomiting
Clinical narrative: Within a couple of hours of receiving the shot I became very nauseous.; Within a couple of hours of receiving the shot I became very nauseous and vomited several times.; Also felt generally under the weather.; Arm pain came on later in the day.; This is a spontaneous report from a non-contactable consumer, the patient. A 56-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6208) via an unspecified route of administration in the left arm on 30Mar2021 at 11:45 (at the age of 56-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 30Mar2021 at 13:15, the patient experienced nauseous after a couple hours of vaccination and vomited several times, also felt generally under the weather. The patient experienced arm pain later in the day. The adverse events did not result in doctor or other healthcare professional office/clinic or emergency room visit. The patient did not receive any treatment for the reported events. The clinical outcome of the events nauseous after a couple hours of vaccination, vomited several times and the arm pain came on later were resolved on an unknown date.    No follow-up attempts are possible. No further information is expected.
Age: 56.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Malaise, Nausea, Pain in extremity, Vomiting
Clinical narrative: Within a couple of hours of receiving the shot I became very nauseous.; Within a couple of hours of receiving the shot I became very nauseous and vomited several times.; Also felt generally under the weather.; Arm pain came on later in the day.; This is a spontaneous report from a non-contactable consumer, the patient. A 56-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6208) via an unspecified route of administration in the left arm on 30Mar2021 at 11:45 (at the age of 56-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 30Mar2021 at 13:15, the patient experienced nauseous after a couple hours of vaccination and vomited several times, also felt generally under the weather. The patient experienced arm pain later in the day. The adverse events did not result in doctor or other healthcare professional office/clinic or emergency room visit. The patient did not receive any treatment for the reported events. The clinical outcome of the events nauseous after a couple hours of vaccination, vomited several times and the arm pain came on later were resolved on an unknown date.    No follow-up attempts are possible. No further information is expected.
Age: 56.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Nausea, Tinnitus, Vomiting
Clinical narrative: Within a couple of hours of receiving the shot I became very nauseous.; Within a couple of hours of receiving the shot I became very nauseous and vomited several times.; Also felt generally under the weather.; Arm pain came on later in the day.; This is a spontaneous report from a non-contactable consumer, the patient. A 56-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6208) via an unspecified route of administration in the left arm on 30Mar2021 at 11:45 (at the age of 56-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 30Mar2021 at 13:15, the patient experienced nauseous after a couple hours of vaccination and vomited several times, also felt generally under the weather. The patient experienced arm pain later in the day. The adverse events did not result in doctor or other healthcare professional office/clinic or emergency room visit. The patient did not receive any treatment for the reported events. The clinical outcome of the events nauseous after a couple hours of vaccination, vomited several times and the arm pain came on later were resolved on an unknown date.    No follow-up attempts are possible. No further information is expected.
Age: 34.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Diarrhoea, Nausea
Clinical narrative: Chronic diarrhea; This is a spontaneous report from a contactable consumer, the patient. A 34-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8737) via an unspecified route of administration in the right arm on 03Apr2021 at 10:15 (at the age of 34-year-old) as a single dose for COVID-19 immunisation. The patient had no medical history. The patient had no known allergies to medications, food or other products. Concomitant medications included ADDERALL XR for an unknown indication from an unknown date. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 04Apr2021 at 06:00, the patient experienced chronic diarrhea. The adverse events did not result in doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. It was unknown if any therapeutic measures were taken as a result of the event chronic diarrhea. The clinical outcome of the event chronic diarrhea was not recovered at the time of reporting.   No follow-up attempts are needed. No further information is expected.
Age: 34.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Diarrhoea
Clinical narrative: Chronic diarrhea; This is a spontaneous report from a contactable consumer, the patient. A 34-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8737) via an unspecified route of administration in the right arm on 03Apr2021 at 10:15 (at the age of 34-year-old) as a single dose for COVID-19 immunisation. The patient had no medical history. The patient had no known allergies to medications, food or other products. Concomitant medications included ADDERALL XR for an unknown indication from an unknown date. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 04Apr2021 at 06:00, the patient experienced chronic diarrhea. The adverse events did not result in doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. It was unknown if any therapeutic measures were taken as a result of the event chronic diarrhea. The clinical outcome of the event chronic diarrhea was not recovered at the time of reporting.   No follow-up attempts are needed. No further information is expected.
Age: 39.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chills, Headache, Hyperhidrosis, Pyrexia
Clinical narrative: Fever 104.1; Chills; Sweats; Body aches; Headache; Fatigue; This is a spontaneous report from a contactable consumer, the patient. A 39-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: EW0151) via an unspecified route of administration in the arm left on 31Mar2021 at 18:30 (at the age of 39-year-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient did not have any allergies to medications, food, or other products. The patient did not receive any other medications within 2 weeks of vaccination. The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: EN6208) via an unspecified route of administration in the left arm on 10Mar2021 at 18:45 (at the age of 39-year-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 01Apr2021 at 07:00 the patient experienced fever 104.1 (unspecified units), chills, sweats, body aches, head ache and fatigue. The patient did not receive any treatment for the events. The events did not result in a visit to the doctors or other healthcare professional office or clinic visit, and emergency room or department or urgent care. The clinical outcome of fever 104.1, chills, sweats, body aches, head ache and fatigue were resolved on unknown date in Apr2021.   No follow-up attempts are needed. No further information is expected.
Age: 39.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Body temperature, Chills, Fatigue, Headache, Hyperhidrosis
Clinical narrative: Fever 104.1; Chills; Sweats; Body aches; Headache; Fatigue; This is a spontaneous report from a contactable consumer, the patient. A 39-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: EW0151) via an unspecified route of administration in the arm left on 31Mar2021 at 18:30 (at the age of 39-year-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient did not have any allergies to medications, food, or other products. The patient did not receive any other medications within 2 weeks of vaccination. The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: EN6208) via an unspecified route of administration in the left arm on 10Mar2021 at 18:45 (at the age of 39-year-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 01Apr2021 at 07:00 the patient experienced fever 104.1 (unspecified units), chills, sweats, body aches, head ache and fatigue. The patient did not receive any treatment for the events. The events did not result in a visit to the doctors or other healthcare professional office or clinic visit, and emergency room or department or urgent care. The clinical outcome of fever 104.1, chills, sweats, body aches, head ache and fatigue were resolved on unknown date in Apr2021.   No follow-up attempts are needed. No further information is expected.
Age: 39.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pain, Pyrexia
Clinical narrative: Fever 104.1; Chills; Sweats; Body aches; Headache; Fatigue; This is a spontaneous report from a contactable consumer, the patient. A 39-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: EW0151) via an unspecified route of administration in the arm left on 31Mar2021 at 18:30 (at the age of 39-year-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient did not have any allergies to medications, food, or other products. The patient did not receive any other medications within 2 weeks of vaccination. The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: EN6208) via an unspecified route of administration in the left arm on 10Mar2021 at 18:45 (at the age of 39-year-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 01Apr2021 at 07:00 the patient experienced fever 104.1 (unspecified units), chills, sweats, body aches, head ache and fatigue. The patient did not receive any treatment for the events. The events did not result in a visit to the doctors or other healthcare professional office or clinic visit, and emergency room or department or urgent care. The clinical outcome of fever 104.1, chills, sweats, body aches, head ache and fatigue were resolved on unknown date in Apr2021.   No follow-up attempts are needed. No further information is expected.
Age: 66.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Ageusia, Dysphagia, Hyperhidrosis, Speech disorder, Swelling face
Clinical narrative: Swelling of face; Spasm in throat; Difficulty swallowing; Numbness; Excessive sweating with taste of covid vaccine; Not feeling like have theteeth.; Tongue tightness; This is a spontaneous report from a contactable consumer, the patient. A 66-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), via an unspecified route of administration in the left arm on an unknown date in Mar2021 (at the age of 66-years-old), as a single dose for COVID-19 immunisation. Medical history included thyroid problem, elevated blood pressure and arthritis. The patient did not have any allergies to medications, food, or other products. The patient received unspecified medications within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 1Apr2021 at 06:00, the patient experienced numbness, swelling of face, tightness, spasm in throat, difficulty swallowing, not feeling like have the teeth, excessive sweating with taste of COVID vaccine. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of the reported events. The clinical outcome of the events numbness, swelling of face, tongue tightness, spasm in throat, difficulty swallowing, not feeling like have the teeth, excessive sweating with taste of COVID vaccine were not resolved at the time of reporting.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 66.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Swollen tongue
Clinical narrative: Swelling of face; Spasm in throat; Difficulty swallowing; Numbness; Excessive sweating with taste of covid vaccine; Not feeling like have theteeth.; Tongue tightness; This is a spontaneous report from a contactable consumer, the patient. A 66-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), via an unspecified route of administration in the left arm on an unknown date in Mar2021 (at the age of 66-years-old), as a single dose for COVID-19 immunisation. Medical history included thyroid problem, elevated blood pressure and arthritis. The patient did not have any allergies to medications, food, or other products. The patient received unspecified medications within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 1Apr2021 at 06:00, the patient experienced numbness, swelling of face, tightness, spasm in throat, difficulty swallowing, not feeling like have the teeth, excessive sweating with taste of COVID vaccine. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of the reported events. The clinical outcome of the events numbness, swelling of face, tongue tightness, spasm in throat, difficulty swallowing, not feeling like have the teeth, excessive sweating with taste of COVID vaccine were not resolved at the time of reporting.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 66.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dysphagia, Hyperhidrosis, Hypoaesthesia, Hypoaesthesia oral, Muscle spasms
Clinical narrative: Swelling of face; Spasm in throat; Difficulty swallowing; Numbness; Excessive sweating with taste of covid vaccine; Not feeling like have theteeth.; Tongue tightness; This is a spontaneous report from a contactable consumer, the patient. A 66-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), via an unspecified route of administration in the left arm on an unknown date in Mar2021 (at the age of 66-years-old), as a single dose for COVID-19 immunisation. Medical history included thyroid problem, elevated blood pressure and arthritis. The patient did not have any allergies to medications, food, or other products. The patient received unspecified medications within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 1Apr2021 at 06:00, the patient experienced numbness, swelling of face, tightness, spasm in throat, difficulty swallowing, not feeling like have the teeth, excessive sweating with taste of COVID vaccine. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of the reported events. The clinical outcome of the events numbness, swelling of face, tongue tightness, spasm in throat, difficulty swallowing, not feeling like have the teeth, excessive sweating with taste of COVID vaccine were not resolved at the time of reporting.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 66.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Swelling face, Tongue discomfort
Clinical narrative: Swelling of face; Spasm in throat; Difficulty swallowing; Numbness; Excessive sweating with taste of covid vaccine; Not feeling like have theteeth.; Tongue tightness; This is a spontaneous report from a contactable consumer, the patient. A 66-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), via an unspecified route of administration in the left arm on an unknown date in Mar2021 (at the age of 66-years-old), as a single dose for COVID-19 immunisation. Medical history included thyroid problem, elevated blood pressure and arthritis. The patient did not have any allergies to medications, food, or other products. The patient received unspecified medications within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 1Apr2021 at 06:00, the patient experienced numbness, swelling of face, tightness, spasm in throat, difficulty swallowing, not feeling like have the teeth, excessive sweating with taste of COVID vaccine. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of the reported events. The clinical outcome of the events numbness, swelling of face, tongue tightness, spasm in throat, difficulty swallowing, not feeling like have the teeth, excessive sweating with taste of COVID vaccine were not resolved at the time of reporting.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 61.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dysphagia, Injection site pruritus, Pruritus, Throat tightness
Clinical narrative: I started to feel itch all  over and throat was scratchy. I was given a benadrly and eppi pen. I was then sent to the emergency room.
Age: 61.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pruritus, Throat irritation
Clinical narrative: I started to feel itch all  over and throat was scratchy. I was given a benadrly and eppi pen. I was then sent to the emergency room.
Age: 57.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Alanine aminotransferase increased, Aspartate aminotransferase increased, Blood creatinine increased, Blood urea increased, Chest X-ray normal
Clinical narrative: Fell ill on April 1st  semi coma on ventilator woke up on April  12
Age: 57.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Culture negative, Dyspnoea, Electrolyte imbalance, Endotracheal intubation, Laboratory test abnormal
Clinical narrative: Fell ill on April 1st  semi coma on ventilator woke up on April  12
Age: 57.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Malaise, Pain, Platelet count decreased, Pyrexia, Sepsis
Clinical narrative: Fell ill on April 1st  semi coma on ventilator woke up on April  12
Age: 57.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: White blood cell count increased
Clinical narrative: Fell ill on April 1st  semi coma on ventilator woke up on April  12
Age: 57.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Depressed level of consciousness, Illness, Mechanical ventilation
Clinical narrative: Fell ill on April 1st  semi coma on ventilator woke up on April  12
Age: 66.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: COVID-19, Pneumonia, SARS-CoV-2 test positive
Clinical narrative: Patient died due to COVID-19. Patient was fully vaccinated.
Age: 66.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: COVID-19, Death
Clinical narrative: Patient died due to COVID-19. Patient was fully vaccinated.
Sex: U
Vaccine: COVID19, COVID19
Symptoms: Cerebrovascular accident, Fall, Gait inability, Laboratory test, Loss of control of legs
Clinical narrative: This is a spontaneous report from a contactable consumer (patient). A patient of unspecified age and gender received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot Number: Unknown, Expiration date: Unknown), via an unspecified route of administration on 18Feb2021 as dose 1, single for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. On an unspecified date in Mar2021, the patient experienced several falls and spasms in left lower leg and foot. The patient was hospitalized from 06Mar2021 to 11Mar2021 for several falls and patient was discharged on 11Mar2021 with no definitive diagnosis with spasms in left lower leg and foot. Patient went to the emergency room on 02Apr2021 with spasms in left leg and to rule out TIA vs CVA. The patient underwent lab tests and procedures which included magnetic resonance imaging results CVA to the right side of brain on 02Apr2021. The outcome of the event several falls was unknown and not recovered for spasms in left lower leg and foot. Information on the lot/batch number has been requested.
Sex: U
Vaccine: COVID19, COVID19
Symptoms: Magnetic resonance imaging head abnormal, Muscle strength abnormal, Muscular weakness
Clinical narrative: This is a spontaneous report from a contactable consumer (patient). A patient of unspecified age and gender received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot Number: Unknown, Expiration date: Unknown), via an unspecified route of administration on 18Feb2021 as dose 1, single for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. On an unspecified date in Mar2021, the patient experienced several falls and spasms in left lower leg and foot. The patient was hospitalized from 06Mar2021 to 11Mar2021 for several falls and patient was discharged on 11Mar2021 with no definitive diagnosis with spasms in left lower leg and foot. Patient went to the emergency room on 02Apr2021 with spasms in left leg and to rule out TIA vs CVA. The patient underwent lab tests and procedures which included magnetic resonance imaging results CVA to the right side of brain on 02Apr2021. The outcome of the event several falls was unknown and not recovered for spasms in left lower leg and foot. Information on the lot/batch number has been requested.
Sex: U
Vaccine: COVID19, COVID19
Symptoms: Fall, Magnetic resonance imaging, Muscle spasms
Clinical narrative: This is a spontaneous report from a contactable consumer (patient). A patient of unspecified age and gender received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot Number: Unknown, Expiration date: Unknown), via an unspecified route of administration on 18Feb2021 as dose 1, single for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. On an unspecified date in Mar2021, the patient experienced several falls and spasms in left lower leg and foot. The patient was hospitalized from 06Mar2021 to 11Mar2021 for several falls and patient was discharged on 11Mar2021 with no definitive diagnosis with spasms in left lower leg and foot. Patient went to the emergency room on 02Apr2021 with spasms in left leg and to rule out TIA vs CVA. The patient underwent lab tests and procedures which included magnetic resonance imaging results CVA to the right side of brain on 02Apr2021. The outcome of the event several falls was unknown and not recovered for spasms in left lower leg and foot. Information on the lot/batch number has been requested.
Age: 16.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Blood creatinine, Blood electrolytes, Blood glucose, Blood urea, Differential white blood cell count
Clinical narrative: Ongoing nausea, off and on for 3months. Nausea began when she received her 1st dose and has continued. Was prescribed Pepcid twice a day and Zofran. Has been thoroughly tested by blood, X-ray, EKG and ultrasound. Spleen measured Enlarged 13.91 but doctors discount this as large for her age and size. The nausea is still ongoing and all test results were normal except for the spleen
Age: 16.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Full blood count, Nausea, Urine analysis normal
Clinical narrative: Ongoing nausea, off and on for 3months. Nausea began when she received her 1st dose and has continued. Was prescribed Pepcid twice a day and Zofran. Has been thoroughly tested by blood, X-ray, EKG and ultrasound. Spleen measured Enlarged 13.91 but doctors discount this as large for her age and size. The nausea is still ongoing and all test results were normal except for the spleen
Age: 16.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Blood test normal, Electrocardiogram normal, Nausea, Splenomegaly, Ultrasound scan
Clinical narrative: Ongoing nausea, off and on for 3months. Nausea began when she received her 1st dose and has continued. Was prescribed Pepcid twice a day and Zofran. Has been thoroughly tested by blood, X-ray, EKG and ultrasound. Spleen measured Enlarged 13.91 but doctors discount this as large for her age and size. The nausea is still ongoing and all test results were normal except for the spleen
Age: 16.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: X-ray
Clinical narrative: Ongoing nausea, off and on for 3months. Nausea began when she received her 1st dose and has continued. Was prescribed Pepcid twice a day and Zofran. Has been thoroughly tested by blood, X-ray, EKG and ultrasound. Spleen measured Enlarged 13.91 but doctors discount this as large for her age and size. The nausea is still ongoing and all test results were normal except for the spleen
Age: 59.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Chest discomfort, Fatigue, Headache, Injection site pain, Lip swelling
Clinical narrative: Swelling of lower right lip and right side of face; Swelling of lower right lip and right side of face; This is a spontaneous report from a contactable consumer (patient). A 59-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE ; lot number was Ep6955 and expiration date was not reported), via an unspecified route of administration, in Left Arm on 31Mar2021 at 14:30 (at the age of 59-years-old) at dose 2, single for COVID-19 immunization. The patient medical history was not reported. Concomitant medications included esomeprazole magnesium (NEXIUM). Patient had no known allergies. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination has not been tested for COVID-19. Historical vaccine included bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE ; lot number was En6206 and expiration date was not reported), via an unspecified route of administration, in Left Arm on 10Mar2021 at 13:00 (at the age of 59-years-old) at dose 1, single for COVID-19 immunization. The patient experienced swelling of lower right lip and right side of face on 01Apr2021 at 08:30. The event resulted in Doctor or other healthcare professional office/clinic visit. Patient was given shot of cortisone as a treatment for the event. The outcome of the events was recovering.
Age: 59.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Muscle spasms, Nausea, Swelling face
Clinical narrative: Swelling of lower right lip and right side of face; Swelling of lower right lip and right side of face; This is a spontaneous report from a contactable consumer (patient). A 59-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE ; lot number was Ep6955 and expiration date was not reported), via an unspecified route of administration, in Left Arm on 31Mar2021 at 14:30 (at the age of 59-years-old) at dose 2, single for COVID-19 immunization. The patient medical history was not reported. Concomitant medications included esomeprazole magnesium (NEXIUM). Patient had no known allergies. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination has not been tested for COVID-19. Historical vaccine included bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE ; lot number was En6206 and expiration date was not reported), via an unspecified route of administration, in Left Arm on 10Mar2021 at 13:00 (at the age of 59-years-old) at dose 1, single for COVID-19 immunization. The patient experienced swelling of lower right lip and right side of face on 01Apr2021 at 08:30. The event resulted in Doctor or other healthcare professional office/clinic visit. Patient was given shot of cortisone as a treatment for the event. The outcome of the events was recovering.
Age: 59.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Lip swelling, Swelling face
Clinical narrative: Swelling of lower right lip and right side of face; Swelling of lower right lip and right side of face; This is a spontaneous report from a contactable consumer (patient). A 59-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE ; lot number was Ep6955 and expiration date was not reported), via an unspecified route of administration, in Left Arm on 31Mar2021 at 14:30 (at the age of 59-years-old) at dose 2, single for COVID-19 immunization. The patient medical history was not reported. Concomitant medications included esomeprazole magnesium (NEXIUM). Patient had no known allergies. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination has not been tested for COVID-19. Historical vaccine included bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE ; lot number was En6206 and expiration date was not reported), via an unspecified route of administration, in Left Arm on 10Mar2021 at 13:00 (at the age of 59-years-old) at dose 1, single for COVID-19 immunization. The patient experienced swelling of lower right lip and right side of face on 01Apr2021 at 08:30. The event resulted in Doctor or other healthcare professional office/clinic visit. Patient was given shot of cortisone as a treatment for the event. The outcome of the events was recovering.
Age: 66.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Fatigue, Mobility decreased, Neck pain
Clinical narrative: vaginal bleeding after approximately 12 years post menopause; abdominal pain; severe headache; neck pain; Periodic heart rate increase.; This is a spontaneous report from a contactable consumer (patient) reported for herself. A 66-years-old female patient (patient was not pregnant at the time of vaccination) received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot number: EW0179, Expiration date: unknown) via an unspecified route of administration, administered in right arm on 05May2021 at 15:30 pm (age at vaccination was 66 years) as dose 1, single for COVID-19 immunization. Medical history included hypothyroidism, atrial flutter, ablation surgery and menopause (age 51). Concomitant medications the patient received within 2 weeks of vaccination included thyroid (ARMOUR THYROID) and acetylsalicylic acid (ASPIRIN) both taken for an unspecified indication. The patient previously took amoxicillin, codeine and nizoral for allergy. The facility where the most recent COVID-19 vaccine was administered was Pharmacy or Drug Store. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. On 06May2021, the day after injection, the patient experienced severe headache and neck pain for several days. On an unspecified date in June2021, the patient experienced abdominal pain and vaginal bleeding after approximately 12 years post-menopausal no bleeding. On an unspecified date in 2021, the patient experienced periodic heart rate increase. The adverse events resulted in Doctor or other healthcare professional office/clinic visit. The patient received treatment with Tylenol for neck and headache. The patient underwent lab tests which included pap test and biopsy with unknown results on an unspecified date. Since the vaccination, the patient has tested for COVID-19. The patient underwent lab tests which included SARS CoV-2 test (other): negative on 24May2021. The outcome of the events severe headache and neck pain was not resolved. The outcome of the other events was unknown.   Follow-up attempts are completed. No further information is expected.  Follow-up (16Jul2021): Follow-up attempts are completed. No further information is expected.